Get complete information related to latest Sirolimus Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Sirolimus Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Sirolimus Tenders.
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapidexchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of thestent to a major government institute. unit:no [ warranty period: 30 months after the date of delivery ] ]
Tender For hq_med_sur_zrc_zonal rate contract for supply of ph:.(153045) sirolimus eluting stent cobalt - chromium stent with abluminal coating and specialised gradient coating (no polymer coating at joint & bends). bioresorbable polymer of plcl (poly lactic acid + poly caprolactone pcl) with degradation time of 3-4 months. low concentration of sirolimus (0.8ug/mm sq) should have bio-inspired open-cell. pmda approved ]
Tender For empanelment for the supply of cathlab items on running contract basis under kasp and other schemes of this hospital - coronary stents, des,everolimus,fda/dcgi/ce approved platinum chromium platform,polyvinylidene fluride-hexafluropropyline pvdf-hfp polymer-stent lengths8,12,16,24,28,32. stent diameter 2.25*,2.50,2.75,3.00,3.50,4.00.struct thickness 81/86 microns.nominal pressure - 11 atm,rated burst pressure 16-18 atm, des,everolimus,fda/ approved platinum chromium platform,polyvinylidene fluoride-hexafluropropylene(pvdf-hfp)polymer, des,everolimus,fda/dcgi/ce/ approved platinum chromium platform,bioabsorbable polymer plga, everolimus eluting platinum chromium stent system, des, everolimus, l 605 cobalt chromium with hybrid cell design , strut thickness- 65microns, polymer- plga diameter- 2.25, 2.5, 2.75, 3.0, 3.5,4. length- 10,13,15,18,20,24, 28, 32,36,40, 42, 44, des, everolimus, cobalt chromium strut thickness - 63 microns . diameter- 2.25,2.5,2.75,3,3.5,4. length- 8,10,13,15,18,20,24,28,32,36,40,42,44. elutes 80% of drugs along with re plga polymer in the first 20 days, dcgi approved everolimus drug eluting 65 micron strut thickness with 3 micron plla&plga. a unique proprietory coating technology basedbiodegradable polymer stent with open cell designed and flexia finished technology based cobalt chromium l605 stent.a designed for optimal strength, flexibility ,trackablity ,side branch supported,bifurcation supported and high radial strength and optimal radiopacity and excellent vessel supported stent with revers alternative link design(ral) stent, with length from 8 mm to 52 mm and diameter from 2.25 mm to 4.50 mm, ce approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., ce approved sirolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 degree with respect to different diameter. the cells are connected by link (mid to mid pattern) with a radius of 0.2700mm. these values have been validated for lower stent profile, uniform expansion, side branch access, good trackability & strong radial support. components - drug: everolimus, stent platform: cobalt chromium l605 alloy, polymer: biodegradable, catheter: ptca rapid exchange semi-compliant stent delivery catheter. drug concentration: 1.2 microgram/mm2 of stent surface area. stent diameter(mm): 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 & stent length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, 47 platinum-iridium radiopaque markers are precisely placed within the balloon cones for accurate stent positioning, also the difference between stent edge to marker is 0.5mm (atboth sides, proximal & distal) which prevents the dogboning during the angioplasty., only dcgi approved everolimus eluting coronary stent system struts/cells shows a wavy pattern and are not straight with outerradius of 0.1725mm. the cell angle is between 42 degree to 57 deg
Tender For supply of polymer free sirolimus eluting coronary stent, with microporous surface, abluminal coating, shellac resin and 10 years of safety and efficacy data. warranty: replacement warranty against any manufacturing defect noted on the o.t. table. [ai(2026-27), item code-no: s-62284, sl no.2183] ]
Tender For bid to ras corrigendum : supply of biodegradable polymer coated cobalt chromium sirolimus drug eluting stent system with ultrathin 60 m , biodegradable polymer co cr sirolimus drug eluting stent with 65 microns strut thickness assorted si
Tender For hq_med_sur_zrc_zonal rate contract for supply of ph:.(153047) biodegradable polymer sirolimus eluting coronary stent with stainless - steel platform having microporous surface, albuminal coating and shellac resin with diameters of 2.0 mm to 4.0 mm of varying length ]
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
Tender For supply of dglp drugs gem 13 pvms 12 series 2026 27 e e - chondroitin sulfate 4percent sterile for intraocular use , tropicamide eye solution 1percent bott of 5 ml , trypan blue 0dot6percent in vial of 1ml inj , chloramphenicol with dexamethasone polymyxin b eye ointment , atropine sulphate 1percent w v bott of 3 ml , atropine sulphate oint 1percent tube of 3 gm , bimatoprost 0dot03percent bott of 3ml , ripasudil 0dot4percent w v eye rops , nepafenac 0dot3percent with carbomer and guar eye suspension , brimonidine 0dot2percent plus timolo 0dot5percent eye drops , gatifloxacin 0dot3percent plus loteprednol 0dot5percent eye drops , moxifloxacin hcl 5mg and dexamethasone phosphate 1mg preservative free ophthalmic solution , nepafenac 0dot1percent w v eye drops , olopatadine hcl 0dot2percent ey drops with drop dispenser technology , polyethylene glycol 400 nf 0dot4percent propylene 0dot3percent , tacrolimus eye ointment 0dot1percent tube of 20gm , tropicamide 0dot8percent w v plus phenylpherine 5percent eye drops , brinzolamide bkc as preservative 0dot01percent , hyaluronidase 1500 iu inj 2ml , tafluprost 0dot0015percent w v eye drops bott of 2dot5ml with dimple technology , syp diphenhydramine 10 15 mg per 5 ml and ammonium chloride 100 150 mg sodium citrate 50 85 mg per 5 ml bottle of 100 ml , fluticasone propionate 50 mcg bp nasal spray , betahistine dihydro chloride 8mg tab , cinnarizine 25 mg tab , prochlorperazine maleate 5mg tab , clotrimazole 1percent w v ip plus lignocaine 2percent w v ip ear drop bott of 10ml , nasal decongestant adult drops xylometazoline hcl 0dot1percent w v nasal drop bottle of 10 ml , xylometazoline hcl 0dot05percent w v nasal solution for paed use bott of 10ml , caffeine citrate 20 mg ml inj 1ml vial , salmetrol 25 mcg plus fluticasone 125mg mdi 120 doses , caffeine 20mg 1ml 1ml syp , liposomal amphotericin b 10 mg vial for injection , cefaclor syp 125mg 5ml bott of 30 ml , midazolam nasal spray0dot5 mg spray 5 ml bottle , linezolid dry powder 100mg 30ml , cetrizine syp 5mg 5ml bott of 60 ml , frusemide 10 mg ml 30 ml syp , cloxacillin syp each 5 ml containing 125 mg of cloxacillin sodium bottle of 30 ml , syp baclofen 1 mg ml , cyproheptadine hcl 2 mg 5 ml bott of 100 ml , domperidone syp 1 mg ml bott of 30 ml , digoxin syp elixir 0dot05mg per ml in 30 ml packages , syp dicyclomine drops of 15 ml , norflox syp 100mg 5ml bott of 30 ml , ondansetron syp 2 mg 5ml in bott of 30 ml , phenobarbitone syp 20 mg 5 ml bott of 60 ml , iron drops paediatric containing ferrous fumerate 25mg ml vit b12 12dot5mg ml and folic acid 200mg ml bott of 15ml , prednisolone syp 5mg 5ml in bott of 30 ml , levo salbutamol syrup 1 mg 5ml bottle of 100 ml , human milk fortifier 2gm sachet , syrup calcium phosphate 80 mg 5 ml 200 ml bottle , tab isoniazid 60 mg plus rifampicin 60 mg , tab dispersable isoniazid 60 mg plus rifampicin 60 mg plus pyrazinamide 150 mg acyclovir ophth ointment 3% w/w in 5 gm tube, timolol maleate 0.5% preservative free with comod system, ciprofloxacin hcl 0.3% tube of 5 gm, cyclopentolate hcl 1% opth soln bottle of 5 ml, ciprofloxacin hcl 0.3% + dexamethasone 0.1 % bott of 5ml, cyclosporine eye drop 0.05% bott of 3 ml, flurbiprofen sodium ophthalmic sol 0.03% vial of 5 ml, gatifloxacin 0.3% eye drop bott of 5 ml, gentamicin sulphate 0.3% w/v gentamicin base with hydrocortisone acetate, homatropine hydrochloride,sol 2%, ketorolac tromethamine 0.4%, eye drops, brimonidine tartrate 0.2%, eye drops, lotepredenole tabonate 0.5% bott of 5 ml, lignocaine hyrochloride 4% topical solution //bid details 2 / 64